Posted BY: Kara | NwoReport

The incidence of heart attacks among individuals aged 50 and below has been on the rise based on data spanning from 2000 to 2016. Surprisingly, even those under 40, who typically have a lower rate of hypertension than their older counterparts, exhibit similar long-term outcomes regarding heart attack incidents. Notably, a 2023 National Geographic article suggests a link between the increasing cases of cardiac arrests among young athletes and the growing number of young adults experiencing heart attacks due to insufficient oxygen supply to the heart muscle. Dr. Peter McCullough, a cardiologist, highlights that adrenaline surges, particularly one during early morning hours and another during physical activity, can trigger cardiac deaths in individuals with myocarditis.

This trend has led to concern about young athletes experiencing cardiac arrests during practices or games. Despite this, specific preventive measures have yet to be noticed. Big Ten schools initiated a comprehensive myocarditis testing program before the COVID-19 vaccination rollout but ceased it despite the vaccine being linked to myocarditis in young men. McCullough underscores that the COVID-19 vaccines induce myocarditis and points out the heightened risk for athletes participating in sports due to adrenaline surges.

Trending: Exploring Pfizer-BioNTech’s Innovative Nucleoside-Modified Messenger RNA (modRNA) Technology for COVID-19 Vaccines: Unveiling Insights from Pfizer Documents

Interestingly, a Yale University press release labeled the numerous cases of myocarditis reported concerning COVID-19 vaccines as “rare” events. Furthermore, McCullough’s research reveals a substantial increase in cardiac arrests post-COVID-19 vaccine release. After introducing the vaccines, he and his colleague discovered a notable rise in cardiac arrests among European soccer and football players.

While COVID-19 testing programs were employed for athletes when the pandemic began, they were discontinued when vaccines were available despite the acknowledged risk of vaccine-induced myocarditis. McCullough criticizes the lack of advanced biomarkers to detect athletes with myocarditis despite the FDA recognizing the vaccine’s side effects. He also highlights the potential underreporting of vaccine-related adverse events in systems like VAERS.

The increasing incidents of heart attacks and cardiac arrests among young adults and athletes suggest an urgent need to focus on cardiovascular disease prevention for this demographic. The complex interplay of factors such as COVID-19 vaccines, myocarditis, and adrenaline surges underscores the importance of vigilance in protecting the heart health of young individuals, especially athletes.